Results 151 to 160 of about 114,880 (265)

Elevated triglyceride‐glucose index is associated with increased risk of chronic kidney disease and end‐stage renal disease in type 1 diabetes: Nationwide cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2784-2794, April 2026.
Abstract Aims Prognostic markers for microvascular complications in type 1 diabetes are needed because factors beyond hyperglycaemia contribute to this risk. The triglyceride‐glucose (TyG) index is an established marker of vascular complications in type 2 diabetes; however, its clinical significance in type 1 diabetes remains unknown.
Rosa Oh, Seohyun Kim, So Hyun Cho, Ji Yoon Kim, Myunghwa Jang, Sang Ho Park, You‐Bin Lee, Sang‐Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim   +10 more
wiley   +1 more source

MicroRNAs and peritoneal dialysis. [PDF]

J Bras Nefrol
Abensur H.
europepmc   +1 more source

Takotsubo Syndrome in the Dialysis Patient - Challenging Diagnosis in a Unique Population. [PDF]

, 2019
Banerjee, Charlotte Perrett, Debasish Banerjee, Foley, Ghadri, Lyon, Pelliccia, Y-Hassan, Yassin, Zbroch   +9 more
core   +1 more source

Meropenem‐Heparin Lock Therapy for Ochrobactrum intermedium Catheter‐Related Bloodstream Infection in a Pediatric Hemodialysis Patient: A Case Report and Literature Review

Hemodialysis International, Volume 30, Issue 2, Page 318-328, April 2026.
ABSTRACT Background In pediatric hemodialysis patients with exhausted vascular access, managing rare pathogens like Ochrobactrum intermedium is challenging, often posing a dilemma between catheter removal and salvage attempts. There are few reports on the supported viability of meropenem‐heparin lock therapy for this purpose in pediatric patients. Case
Mônica Cristina Dutra Rodrigues, Fernanda Teixeira Sillva, Anderson Pereira de Oliveira, Yeo Jim Kinoshita Moon, Jhohann Richard de Lima Benzi   +4 more
wiley   +1 more source

Efficacy and safety of sacubitril/valsartan in patients on peritoneal dialysis: a systematic review and meta-analysis. [PDF]

J Bras Nefrol
Silva CLD, Fonseca PEO, Calice-Silva V, Ponce D, Rocha PN, Guimarães MG.   +5 more
europepmc   +1 more source

Peritoneal dialysis and heart failure. [PDF]

Curr Opin Nephrol Hypertens
Hsu CM, Weiner DE, McCallum W.
europepmc   +1 more source

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

Journal of Diabetes Investigation, Volume 17, Issue 4, Page 636-648, April 2026.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio, Ryotaro Bouchi, Mitsuhisa Komatsu, Masanori Yamazaki, Daisuke Takarabe, Masahide Okamoto, Takahisa Tanaka, Toru Kitazawa, Hisayuki Katsuyama, Yasumichi Mori, Mitsuhiko Noda   +10 more
wiley   +1 more source

Outcomes of diabetic patients undergoing peritoneal dialysis in the French Language Peritoneal Dialysis Registry. [PDF]

Clin Kidney J
Khachroumi N, Boyer A, Lanot A, Ficheux M, Bechade C, Lobbedez T.   +5 more
europepmc   +1 more source

Management of Hypertension in Patients Undergoing Peritoneal Dialysis: A Narrative Review. [PDF]

Cureus
Ramlal AA, Naimat A, Ramakrishnan A, Pattathil M, Shahbaz T, Tariq Y, Bodige M, Irum Z, Dontul V, Ali A, Jaber M.   +10 more
europepmc   +1 more source

Intramuscular fat content and the risk of peritonitis in peritoneal dialysis patients. [PDF]

Clin Kidney J
Xu L, Ng JK, Fung WW, Chan GC, Pang WF, Chow KM, Szeto CC.   +6 more
europepmc   +1 more source